Thema
Journal Article
102
Influenza Vaccines
61
Research Support, Non-U.S. Gov't
48
Vaccines, Attenuated
44
Antibodies, Viral
38
Influenza
18
Review
17
live attenuated influenza vaccine
17
615
15
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
15
che
15
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
14
bio
14
influenza
12
Antibodies, Neutralizing
11
SARS-CoV-2
11
Hemagglutinin Glycoproteins, Influenza Virus
10
Live attenuated influenza vaccine
10
Randomized Controlled Trial
10
Vaccines, Inactivated
8
immunogenicity
8
Immunoglobulin A
7
universal influenza vaccine
7
COVID-19
6
Clinical Trial, Phase I
6
Comparative Study
6
Influenza Virus
6
Neuraminidase
6
cross-protection
6
Cross-protection
5
Editorial
5
Immunoglobulin G
5
Universal influenza vaccine
5
Vaccines, Synthetic
5
Viral Proteins
5
safety
5
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
4
COVID-19 Vaccines
4
EC 3.2.1.18
4
Epitopes
4
Epitopes, T-Lymphocyte
4
Hemagglutination Inhibition
4
LAIV
4
Research Support, N.I.H., Extramural
4
clinical trial
4
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
3
Clinical Trial, Phase II
3
Conserved protein
3
Hemagglutinins
3
IgG
3
mehr ...